ESCRS Homepage

December 2002
IN THIS ISSUE

Transcleral drugs overcome usual delivery limitations


Wavefront rated in 'top five' innovations of last 25 years

Ultrasound tool 'crystal ball' for anterior surgeons

Task force develops classification system for retinopathy screening

Cool laser blasts way to micro-incision cataract surgery

Anterior chamber maintainer adequate for micro surgery

Artemis 2 provides 'unprecedented' diagnostic readings

Laser biometry more reliable with experts and novices

In search of objective accommodation evaluation

Cataract surgery more than meets front of the eye

Combined surgery safe for PEX patients

Deferring PI in filtering surgery does not increase risks

Early glaucoma intervention delays progression

Oxygen may be the culprit in nuclear cataract

New IOL accommodates cataract patients

Trainee surgeons hold didactic wisdom

Antiviral treatment best defence for ocular herpes

Sutureless surgery advances with help of corneal glue

New weapons in the fight against corneal infection

New weapons in the fight against corneal infection

Intravitreal triamcinolone could reduce need for PDT re-treatment in eyes with exudative AMD

Ultra-thin lens reveals mystery accommodation

Two IOL styles prove to be equally accommodating in comparative trial

New drug improves diabetic retinopathy therapy

Good long-term results with combination surgery

Treating ocular cancer with designer molecules

Clear lens extraction prompts vitreoretinal concern

Roots of Fuchs' dystrophy may be found in mitochondrial genes

FEATURES
From The Editor
Reflections on Refractive Surgery
In Your Good Books
Bio-ophthalmology
Beyond The Eye
Regulatory Matters



Good long-term results with combination surgery

By Ana Hidalgo-Simón MD, PhD

NICE - Good results are achieved with combined glaucoma non-penetrating deep sclerectomy and phacoemulsification, according to the results of a new prospective Italian study presented at the XX ESCRS Congress.
Researchers at the University of Modena conducted a prospective study to evaluate IOP control in patients who were operated on for glaucoma and cataracts at the same time.

The study enrolled 45 patients, all with glaucoma and cataracts with a visual acuity of
0.4 or less. The trial included patients with an uncontrolled IOP despite maximum medication or patients with advanced glaucomatous damage despite being on two or three medications.

At the two-year follow-up point, most patients still had clear vision and controlled IOP, Martini Enrico MD reported.
The average preoperative uncontrolled IOP was 23.2 mm Hg. One month after the operation, IOP was 14.7 mm Hg and at six months it was 14.9 mm Hg. At one year, the average IOP had increased to 15.5 mm Hg and 16.1 mm Hg after two years.

At the end of the two-year study period, 80% of the procedures were considered complete successes with IOP levels remaining under 18 mm Hg without therapy.
In another four eyes, it was possible to maintain IOP below 18 mm Hg with the help of drug therapy, bringing to 90% the cases that could be considered qualified successes. Four eyes were failures, insofar as IOP was not kept under 18 mm Hg even with drug therapy.

Seven eyes (17.5%) required YAG goniopuncture and another five (12.5%) received 5 FU injections. Macroperforations were very rare.
Two of the 45 eyes included in the study were converted to trabeculectomy during surgery. Iris prolapse was the most common postoperative complication, he reported.

The surgical technique used was a two-site procedure with temporal phacoemulsification and foldable IOL implantation for cataract removal and non-penetrating deep sclerectomy without the use of anti-mitotic drugs for glaucoma correction. Peribulbar anaesthesia was used in all cases.

"When compared to other methods, combined phacosclerectomy shows similar results in visual acuity but achieves a better IOP control and survival rate of the filtration bleb.
"The success at two years is very satisfactory, even if there is a tendency towards increased mean IOP. We feel this technique may be considered the first choice for combined cataract and glaucoma surgery," he noted.

Top